Journal article icon

Journal article

11β-Hydroxysteroid dehydrogenase type 1 as a therapeutic target in the metabolic syndrome

Abstract:
The global epidemic of obesity and the metabolic syndrome has focused the need for novel treatments. Here we describe the putative pathogenic role of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), an enzyme that generates active glucocorticoid, cortisol, within liver and adipose tissue. Furthermore, we review the published literature on the development of selective 11β-HSD1 inhibitors as a therapeutic strategy in light of their emerging role as insulin sensitisers. © 2005 Elsevier Ltd. All rights reserved.

Actions

Access Document

Publisher copy:
10.1016/j.ddstr.2005.05.006

Authors


Journal:
Drug Discovery Today: Therapeutic Strategies More from this journal
Volume:
2
Issue:
2
Pages:
93-96
Publication date:
2005-01-01
DOI:
ISSN:
1740-6773


Language:
English
Pubs id:
pubs:482142
UUID:
uuid:02478362-4e41-4093-9e54-29913d26482e
Local pid:
pubs:482142
Source identifiers:
482142
Deposit date:
2014-08-29
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP